Terry Moore

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Generic omeprazole delayed-release capsules: in vitro performance evaluations
    Terry Moore
    Office of Testing and Research, Division of Pharmaceutical Analysis, Food and Drug Administration, St Louis, MO 63101, USA
    Drug Dev Ind Pharm 35:917-21. 2009
  2. ncbi Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note
    Zongming Gao
    Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis, St Louis, MO 63101, USA
    AAPS PharmSciTech 8:E82. 2007
  3. ncbi Delayed release tablet dissolution related to coating thickness by terahertz pulsed image mapping
    John A Spencer
    U S Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market Street, St Louis, Missouri 63101, USA
    J Pharm Sci 97:1543-50. 2008
  4. ncbi Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection
    Michael E Hadwiger
    Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market St, Saint Louis, MO 63101, USA
    J Chromatogr A 1217:7547-55. 2010

Detail Information

Publications4

  1. ncbi Generic omeprazole delayed-release capsules: in vitro performance evaluations
    Terry Moore
    Office of Testing and Research, Division of Pharmaceutical Analysis, Food and Drug Administration, St Louis, MO 63101, USA
    Drug Dev Ind Pharm 35:917-21. 2009
    ..FDA has received some complaints concerning a lack of therapeutic effect of the generic omeprazole delayed-release capsules. Aim: To investigate the quality of five different marketed generic omeprazole delayed-release capsules...
  2. ncbi Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note
    Zongming Gao
    Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis, St Louis, MO 63101, USA
    AAPS PharmSciTech 8:E82. 2007
  3. ncbi Delayed release tablet dissolution related to coating thickness by terahertz pulsed image mapping
    John A Spencer
    U S Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market Street, St Louis, Missouri 63101, USA
    J Pharm Sci 97:1543-50. 2008
    ..The speed and ease of TPI mapping may make it an attractive replacement for wet dissolution testing both in product development and eventually for process analysis...
  4. ncbi Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection
    Michael E Hadwiger
    Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market St, Saint Louis, MO 63101, USA
    J Chromatogr A 1217:7547-55. 2010
    ..Identification was accomplished by comparing the retention time of relevant peaks in the sample with those of standard compounds, in addition to comparison of the UV spectra, mass spectra and/or product ion mass spectra...